You are 3 steps away
from making better decisions

Serving leading biopharmaceutical companies globally:

Dow
Boehringer Ingelheim
Moodys
Merck
Colorcon
McKinsey

Last Updated: November 24, 2020

DrugPatentWatch Database Preview

CLINICAL TRIALS PROFILE FOR NICOTROL

➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing

« Back to Dashboard

All Clinical Trials for Nicotrol

Trial ID Title Status Sponsor Phase Start Date Summary
NCT00091468 Nicotine Treatment of Mild Cognitive Impairment (MCI) Unknown status National Institute on Aging (NIA) Phase 1 2003-09-01 The purpose of this 12-month study is to determine whether nicotine, administered in the form of nicotine patches, can improve symptoms of memory loss in some people experiencing mild memory problems (referred to in this study as "mild cognitive impairment" or MCI).
NCT00108342 Nicotine Delivery Systems: Research & Treatment Terminated VA Office of Research and Development N/A 2007-10-01 The purpose of this study is to determine whether sampling nicotine replacement treatments (NRTs) is superior to learning about them by computer. Testing also covers preferences among the treatments. Subjects will be enrolled veterans who smoke. Hypothesis: Direct experience ("sampling") of NRTs will increase knowledge about NRTs, motivation/confidence, use of NRTs and quit attempts in contrast to learning about NRTs by computer.
NCT00326781 Bio-Behavioral Predictors of the Efficacy of Nicotine Replacement Therapy (NRT) Completed National Cancer Institute (NCI) Phase 4 1999-12-01 The purpose of this research study is to: 1. compare the effectiveness of a nicotine patch and nicotine nasal spray for smoking cessation; and 2. identify predictors of response to these alternate forms of nicotine replacement therapy (NRT).
NCT00326781 Bio-Behavioral Predictors of the Efficacy of Nicotine Replacement Therapy (NRT) Completed University of Pennsylvania Phase 4 1999-12-01 The purpose of this research study is to: 1. compare the effectiveness of a nicotine patch and nicotine nasal spray for smoking cessation; and 2. identify predictors of response to these alternate forms of nicotine replacement therapy (NRT).
NCT00440830 Nicotine Patch as an Analgesic Adjuvant After Surgery Completed Columbia University Phase 4 2005-12-01 Effect of nicotine patch as an adjutant for acute pain after surgery.
NCT00954096 Nicotine Patch, Blood Flow and Oxidative Stress Study Completed National Institutes of Health (NIH) N/A 2002-10-01 This study will address the hypothesis that nicotine, like cigarette smoking acting as a pro-oxidant may have adverse effects on arterial function.
NCT00954096 Nicotine Patch, Blood Flow and Oxidative Stress Study Completed University of Pennsylvania N/A 2002-10-01 This study will address the hypothesis that nicotine, like cigarette smoking acting as a pro-oxidant may have adverse effects on arterial function.
>Trial ID >Title >Status >Phase >Start Date >Summary

Clinical Trial Conditions for Nicotrol

Condition Name

Condition Name for Nicotrol
Intervention Trials
Smoking 2
Healthy 1
Depressive Disorder 1
Smoking Cessation 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Condition MeSH

Condition MeSH for Nicotrol
Intervention Trials
Schizophrenia 1
Mild Cognitive Impairment 1
Memory Disorders 1
Cognition Disorders 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Locations for Nicotrol

Trials by Country

Trials by Country for Nicotrol
Location Trials
United States 10
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Trials by US State

Trials by US State for Nicotrol
Location Trials
Pennsylvania 2
California 2
Tennessee 1
New Jersey 1
New York 1
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Progress for Nicotrol

Clinical Trial Phase

Clinical Trial Phase for Nicotrol
Clinical Trial Phase Trials
Phase 4 3
Phase 2 2
Phase 1 2
[disabled in preview] 2
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Status

Clinical Trial Status for Nicotrol
Clinical Trial Phase Trials
Completed 4
Not yet recruiting 3
Terminated 1
[disabled in preview] 1
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Sponsors for Nicotrol

Sponsor Name

Sponsor Name for Nicotrol
Sponsor Trials
University of Pennsylvania 2
National Institute on Drug Abuse (NIDA) 2
NJOY, Inc. 1
[disabled in preview] 4
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Sponsor Type

Sponsor Type for Nicotrol
Sponsor Trials
Other 8
NIH 5
U.S. Fed 1
[disabled in preview] 1
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Express Scripts
AstraZeneca
Mallinckrodt
Boehringer Ingelheim
McKesson
Colorcon

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.